Startups · AI

Senior / Staff Robotics Research Scientist - Dexterous & Mobile Manipulation

Multiply Labs · San Francisco · On-site

← All jobs
About Multiply Labs

Backed by Y Combinator and Lux.

About the role

At Multiply Labs, we are applying AI to solve complex manipulation challenges in robotic cell therapy manufacturing. We're looking for a Research Scientist specializing in robotic manipulation to develop the next generation of our intelligent robotic systems.

What they're looking for

  • MS or PhD in a robotics-relevant field
  • 5+ years of experience in research and development
  • A strong theoretical and practical understanding of modern approaches for robotic manipulation, which might include imitation learning, reinforcement learning, and vision-language-action (VLA) models
  • High proficiency with Python and deep learning frameworks (e.g., PyTorch)
  • Experience collaborating in large and complex code bases
  • Experience with modern robotics simulation environments designed for ML (e.g., Isaac Sim, MuJoCo, PyBullet)
More about this role

Join the Future of Robotic Biomanufacturing!

Multiply Labs is a robotics company on a mission to solve a significant bottleneck in modern medicine: the manufacturing of life-saving advanced biologics, from gene and cell therapies to antibodies and more.

Today, these therapies are produced through manual, labor-intensive processes. Costs are extremely high—often $500K–$2M per patient—limiting access to only a small fraction of those who need them.

As product complexity increases and the cost of failure and scientific labor rises, the industry is shifting toward automation. Robotics and AI are making automated biologics manufacturing feasible, reliable, and economically scalable.

We believe the future of biomanufacturing is robotic—closed, automated, and scalable—ensuring critical therapeutics are accessible to every patient who needs them.

Why This Matters

We don’t just build robots; we build the infrastructure for the next generation of biologics manufacturing. Our technology allows biopharma companies to scale production without redesigning their science, drastically lowering regulatory hurdles and bringing costs down to a level where these treatments can actually reach...

Read the full posting on Multiply Labs's site ↗

Advanced Software R&D

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.